FLT3 INTERNAL TANDEM DUPLICATION POSITIVE

Clinical trials for FLT3 INTERNAL TANDEM DUPLICATION POSITIVE explained in plain language.

Never miss a new study

Get alerted when new FLT3 INTERNAL TANDEM DUPLICATION POSITIVE trials appear

Sign up with your email to follow new studies for FLT3 INTERNAL TANDEM DUPLICATION POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug strategy aims to spare leukemia patients from stem cell transplants

Disease control Recruiting now

This study is testing a new treatment plan for adults with a specific genetic type of acute myeloid leukemia (AML). The goal is to see if a combination of targeted drugs and chemotherapy can control the cancer so well that patients might not need a stem cell transplant, which is …

Matched conditions: FLT3 INTERNAL TANDEM DUPLICATION POSITIVE

Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control

Last updated Apr 04, 2026 07:51 UTC

FLT3 INTERNAL TANDEM DUPLICATION POSITIVE

Get alerted when new FLT3 INTERNAL TANDEM DUPLICATION POSITIVE trials appear

New drug strategy aims to spare leukemia patients from stem cell transplants